ArticleScientific reports2025
Gal4 drivers of the geosmin receptor Or56a exhibit ectopic expression in the labral sense organ of Drosophila.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The fruit fly, Drosophila melanogaster, is a valuable model for studying the mechanisms of chemosensation. The odorant receptor Or56a has been shown to be narrowly tuned to geosmin-a chemical that flies use as a proxy for toxic molds and bacteria-and its activation drives olfactory avoidance behavior. Here, I find that existing Gal4 drivers using cloned promoter fragments of the Or56a gene drive unexpected expression in the labral sense organ (LSO), an internal taste sensory organ within the fly pharynx, in addition to their reported expression in the olfactory antennae. However, the presence of geosmin in sucrose solution does not elicit taste aversion or reduce consumption. Furthermore, a knock-in Or56a-T2A-Gal4 line newly generated in this study does not drive expression in the LSO. These results suggest that the LSO expression likely reflects ectopic expression from the existing Or56a-Gal4 drivers rather than the endogenous Or56a expression pattern. This study adds to the growing evidence that genetic drivers constructed using cloned promoters may not always faithfully recapitulate endogenous gene expression patterns, which should be taken into consideration when interpreting experimental results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.